391 related articles for article (PubMed ID: 30551451)
1. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
Cao XZ; Bin H; Zang ZN
Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
[TBL] [Abstract][Full Text] [Related]
2. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
Xue KC; Hu DD; Zhao L; Li N; Shen HY
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
[TBL] [Abstract][Full Text] [Related]
3. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
Li R; Liu J; Li Q; Chen G; Yu X
Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
[TBL] [Abstract][Full Text] [Related]
4. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
6. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
[TBL] [Abstract][Full Text] [Related]
9. miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.
Liang X; Li Z; Men Q; Li Y; Li H; Chong T
Biomed Pharmacother; 2018 Dec; 108():574-583. PubMed ID: 30243091
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2.
Wang XZ; Hang YK; Liu JB; Hou YQ; Wang N; Wang MJ
J Pharmacol Sci; 2016 Feb; 130(2):78-84. PubMed ID: 26806295
[TBL] [Abstract][Full Text] [Related]
11. MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma.
Diao Y; Fu H; Wang Q
Am J Ther; 2017 May; 24(3):e317-e328. PubMed ID: 27077469
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
Sun Y; Shi T; Ma Y; Qin H; Li K
Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.
Qiu W; Yang Z; Fan Y; Zheng Q
Oncotarget; 2016 Jun; 7(26):39907-39915. PubMed ID: 27223438
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
15. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
16. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
17. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY
Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.
Liang W; Xie Z; Cui W; Guo Y; Xu L; Wu J; Guan H
J Cancer Res Clin Oncol; 2017 Apr; 143(4):601-611. PubMed ID: 27942860
[TBL] [Abstract][Full Text] [Related]
20. microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.
Carvalheira G; Nozima BH; Cerutti JM
Oncotarget; 2015 Sep; 6(29):28357-70. PubMed ID: 26317551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]